Evidence map›Paper›PMID 33913390›Full record

ArticleScience progress

The role of oxidant-antioxidant markers and resistin in metabolic syndrome elderly individuals.

Sylwia Dzięgielewska-Gęsiak, Karolina Wyszomirska, Edyta Fatyga, Ewa Wysocka, Małgorzata Muc-Wierzgoń

Open access · diamondAbstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Relationship Between Small Dense Low-Density Lipoprotein Cholesterol and Metabolic Syndrome.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  10. Review
  11. Review
  12. Review
  13. Osteoclasts May Affect Glucose Uptake-Related Insulin Resistance by Secreting Resistin.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sylwia Dzięgielewska-GęsiakDepartment of Internal Medicine, Medical University of Silesia in Katowice, Bytom, Poland.ORCID 0000-0003-1019-5959
Karolina WyszomirskaDepartment of Clinical Biochemistry and Laboratory Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Edyta FatygaDepartment of Internal Medicine, Medical University of Silesia in Katowice, Bytom, Poland.
Ewa WysockaChair and Department of Laboratory Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.
Małgorzata Muc-WierzgońDepartment of Internal Medicine, Medical University of Silesia in Katowice, Bytom, Poland.
Medical University of Silesia · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In elderly, hormones and oxidant-antioxidant interplay are suggested to mediate biochemical balance between adipose tissue to other tissues. Thus the study attempts to explore metabolic traits, plasma resistin, and oxidant-antioxidant markers in metabolic syndrome (MetS) in comparison to non-metabolic syndrome (non-MetS) elderly individuals. A total of 541 healthy elderly Caucasians, with no acute and/or chronic disorders were invited. After taking into account inclusion/exclusion criteria's the MetS was defined as the presence of three out of five abnormal findings and allowed to divided groups into: non-metabolic syndrome, non-MetS (

Indexed as

AntioxidantsMetabolic SyndromeAgedBiomarkersGlucoseHumansOxidantsResistinSuperoxide DismutaseAntioxidantsBiomarkersGlucoseOxidantsResistinSuperoxide Dismutaseantioxidant markerselderlyMetabolic syndromeoxidative stressresistin

Identifiers

PMID33913390
PMCPMC10364936
OpenAlexW3158904886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.